• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by P3 Health Partners Inc. (Amendment)

    2/12/24 4:22:12 PM ET
    $PIII
    Medical/Nursing Services
    Health Care
    Get the next $PIII alert in real time by email
    SC 13G/A 1 form_sc13ga-p3health.htm
      
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     __________________________________

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 2)*
     
     __________________________________

    P3 Health Partners Inc.
    (Name of Issuer)
    Class A Common Stock, $0.0001 par value per share
    (Title of Class of Securities)
    744413105
    (CUSIP Number)
    December 31, 2023
    (Date of event which requires filing of this statement)
     
      __________________________________

    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
    ☒ Rule 13d-1(b) 
    ☐ Rule 13d-1(c) 
    ☐ Rule 13d-1(d) 
     
     *
    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

             
    CUSIP No. 744413105
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners LLP
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Kingdom
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    2,546,924 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    2,546,924 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    2,546,924 (1)
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.2% (1)(2)
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    PN, IA
     
    (1)
    Includes 2,546,924 shares of Class A Common Stock of P3 Health Partners Inc. (the “Issuer”) issuable upon the exercise of warrants.
    (2)
    Based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 8, 2023.

             
    CUSIP No. 744413105
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners Limited
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Hong Kong
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    2,546,924 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    2,546,924 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    2,546,924 (1)
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.2% (1)(2)
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    CO, IA
     
    (1)
    Includes 2,546,924 shares of Class A Common Stock of the Issuer issuable upon the exercise of warrants.
    (2)
    Based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the SEC on November 8, 2023.

             
    CUSIP No. 744413105
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners LLC
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    State of Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    2,546,924 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    2,546,924 (1)
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    2,546,924 (1)
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.2% (1)(2)
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    OO, IA
     
    (1)
    Includes 2,546,924 shares of Class A Common Stock of the Issuer issuable upon the exercise of warrants.
    (2)
    Based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the SEC on November 8, 2023.

             
    CUSIP No. 744413105
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners AG
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Switzerland
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    2,546,924 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    2,546,924 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    2,546,924 (1)
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.2% (1)(2)
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    CO, IA
     
    (1)
    Includes 2,546,924 shares of Class A Common Stock of the Issuer issuable upon the exercise of warrants.
    (2)
    Based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the SEC on November 8, 2023.

             
    CUSIP No. 744413105
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    LMR Partners (DIFC) Limited
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Arab Emirates
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    2,546,924 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    2,546,924 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    2,546,924 (1)
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.2% (1)(2)
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    CO, IA
     
    (1)
    Includes 2,546,924 shares of Class A Common Stock of the Issuer issuable upon the exercise of warrants.
    (2)
    Based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the SEC on November 8, 2023.

             
    CUSIP No. 744413105
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    Ben Levine
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Kingdom
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    2,546,924 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    2,546,924 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    2,546,924 (1)
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.2% (1)(2)
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    IN, HC
     
    (1)
    Includes 2,546,924 shares of Class A Common Stock of the Issuer issuable upon the exercise of warrants.
    (2)
    Based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the SEC on November 8, 2023.

             
    CUSIP No. 744413105
     
    13G
     
     
     
                 
    1
     
    NAMES OF REPORTING PERSONS
     
    Stefan Renold
    2
     
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) ☐ (b) ☐
     
    3
     
    SEC USE ONLY
     
    4
     
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Switzerland
                 
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
     
    5
     
    SOLE VOTING POWER
     
    0
     
    6
     
    SHARED VOTING POWER
     
    2,546,924 (1)
     
    7
     
    SOLE DISPOSITIVE POWER
     
    0
     
    8
     
    SHARED DISPOSITIVE POWER
     
    2,546,924 (1)
                 
    9
     
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    2,546,924 (1)
    10
     
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
    ☐
    11
     
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.2% (1)(2)
    12
     
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
    IN, HC
     
    (1)
    Includes 2,546,924 shares of Class A Common Stock of the Issuer issuable upon the exercise of warrants.
    (2)
    Based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the SEC on November 8, 2023.

    Item 1(a).
    NAME OF ISSUER:

    The name of the issuer is P3 Health Partners Inc. (the “Issuer”).
     
    Item 1(b).
    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

    The Issuer’s principal executive offices are located at 2370 Corporate Circle, Suite 300, Henderson, NV 89074.
     
    Item 2(a).
    NAME OF PERSON FILING:

    This statement is filed by:
     
      
    (i)
    LMR Partners LLP, LMR Partners Limited, LMR Partners LLC, LMR Partners AG and LMR Partners (DIFC) Limited (collectively, the “LMR Investment Managers”), which serve as the investment managers to certain funds with respect to the shares of Class A Common Stock (as defined in Item 2(d)) held by certain funds; and
      
    (ii)
    Ben Levine and Stefan Renold, who are ultimately in control of the investment and voting decisions of the LMR Investment Managers with respect to the securities held by certain funds.

    The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.”
     
    Item 2(b).
    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

    The address of the principal business office of each of the Reporting Persons is c/o LMR Partners LLP, 9th Floor, Devonshire House, 1 Mayfair Place, London, W1J 8AJ, United Kingdom.
     
    Item 2(c).
    CITIZENSHIP:

    LMR Partners LLP is a United Kingdom limited liability partnership. LMR Partners Limited is a Hong Kong corporation. LMR Partners LLC is a Delaware limited liability company. LMR Partners AG is a Swiss corporation. LMR Partners (DIFC) Limited is a United Arab Emirates corporation. Ben Levine is a citizen of the United Kingdom. Stefan Renold is a citizen of Switzerland.
     
    Item 2(d).
    TITLE OF CLASS OF SECURITIES:

    Class A Common Stock, $0.0001 par value per share (“Class A Common Stock”).
     
    Item 2(e).
    CUSIP NUMBER:

    744413105



    Item 3.
    IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
     
             
    (a)
     
    ☐
     
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c).
         
    (b)
     
    ☐
     
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
         
    (c)
     
    ☐
     
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
         
    (d)
     
    ☐
     
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
         
    (e)
     
    ☒
     
    An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
         
    (f)
     
    ☐
     
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
         
    (g)
     
    ☒
     
    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
         
    (h)
     
    ☐
     
    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
         
    (i)
     
    ☐
     
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
         
    (j)
     
    ☒
     
    A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
         
    (k)
     
    ☐
     
    Group, in accordance with §240.13d-1(b)(1)(ii)(K).
    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: investment adviser
     
    Item 4.
    OWNERSHIP.

    The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

    Each of LMR Multi-Strategy Master Fund Limited (“LMR Master Fund”) and LMR CCSA Master Fund Ltd (“LMR CCSA Master Fund”) directly holds warrants to purchase 1,273,462 shares of Class A Common Stock (“Warrants”). The shares of Class A Common Stock held by each of LMR Master Fund and LMR CCSA Master Fund represent approximately 1.1% and the shares of Class A Common Stock held by LMR Master Fund and LMR CCSA Master Fund in the aggregate represent approximately 2.2% of the outstanding shares of Class A Common Stock, based on 115,242,028 shares of Class A Common Stock of the Issuer outstanding as of November 1, 2023, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 8, 2023, plus shares that may be acquired by such Reporting Persons within 60 days.

    LMR Master Fund and LMR CCSA Master Fund are no longer reporting as beneficial owners because they do not retain voting or investment control over the securities that they hold.
     
    Item 5.
    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owners of more than five percent of the class of securities, check the following ☒.

    Item 6.
    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

    Not applicable.
     
    Item 7.
    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

    Not applicable.
     


    Item 8.
    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

    Not applicable.
     
    Item 9.
    NOTICE OF DISSOLUTION OF GROUP.

    Not applicable.
     
    Item 10.
    CERTIFICATION.

    Each of the LMR Investment Managers and Messrs. Levine and Renold hereby certifies as follows:

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Each of the LMR Investment Managers other than LMR Partners LLC hereby certifies as follows:

    By signing below, I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to an investment adviser is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Securities and Exchange Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.

    SIGNATURES

    After reasonable inquiry and to the best of our knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATED: February 12, 2024

    LMR PARTNERS LLP
     
    By: /s/ Shane Cullinane
    Name: Shane Cullinane
    Title: Chief Operating Officer
     
    LMR PARTNERS LIMITED
     
    By: /s/ Shane Cullinane
    Name: Shane Cullinane
    Title: Chief Operating Officer
     
    LMR PARTNERS LLC
     
    By: /s/ Shane Cullinane
    Name: Shane Cullinane
    Title: Chief Operating Officer
     
    LMR PARTNERS AG
     
    By: /s/ Shane Cullinane
    Name: Shane Cullinane
    Title: Chief Operating Officer

    LMR PARTNERS (DIFC) LIMITED
     
    By: /s/ Shane Cullinane
    Name: Shane Cullinane
    Title: Chief Operating Officer

    /s/ Ben Levine
    BEN LEVINE

    /s/ Stefan Renold
    STEFAN RENOLD
     

    Get the next $PIII alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PIII

    DatePrice TargetRatingAnalyst
    4/1/2024Buy → Neutral
    BTIG Research
    9/1/2023$5.00Buy
    BTIG Research
    6/30/2023Market Perform
    TD Cowen
    1/4/2022Outperform
    William Blair
    More analyst ratings

    $PIII
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 15, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

      5/8/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will give a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3's investor relations webpage for 30 days following the presentation. About P3 Health Partners (NASDAQ:PIII): P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the

      4/2/25 8:05:00 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

      Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. "Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention," said Aric Coffman, CEO of P3. "With the $130M+ in identified programmatic opportunities advancing our path to financial su

      3/27/25 4:22:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Financials

    Live finance-specific insights

    See more
    • P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 15, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

      5/8/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

      Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. "Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention," said Aric Coffman, CEO of P3. "With the $130M+ in identified programmatic opportunities advancing our path to financial su

      3/27/25 4:22:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter Earnings Conference Call Date & Time March 27, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call   The conference call will

      3/13/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by P3 Health Partners Inc.

      SC 13G - P3 Health Partners Inc. (0001832511) (Subject)

      11/14/24 4:33:46 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

      SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

      11/8/24 5:15:05 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

      SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

      6/26/24 4:30:49 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    SEC Filings

    See more
    • SEC Form DEF 14A filed by P3 Health Partners Inc.

      DEF 14A - P3 Health Partners Inc. (0001832511) (Filer)

      4/29/25 4:27:49 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • SEC Form PRE 14A filed by P3 Health Partners Inc.

      PRE 14A - P3 Health Partners Inc. (0001832511) (Filer)

      4/18/25 5:28:07 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - P3 Health Partners Inc. (0001832511) (Filer)

      4/16/25 8:09:19 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Leadership Updates

    Live Leadership Updates

    See more
    • P3 Health Partners Names Leif Pedersen New Chief Financial Officer

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company. Pedersen was most recently Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Prior to Optum Health, Pedersen served as Vice President of Finance & CFO IT at DaVita Medical Group. He brings m

      8/29/24 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Names Dr. Aric Coffman as CEO

      P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3's Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company's Board of Directors working closely with Dr. Coffman to ensure a smooth transition. Dr. Coffman is an exceptional physician leader with a proven track record of success in the value-based care sector, most recently as the CEO of Honest Medical Group, a Rubicon Founders portfolio company. He brings over two decades of experience in leading provider organizations in delivering high quality, highly effici

      5/8/24 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • P3 Health Partners downgraded by BTIG Research

      BTIG Research downgraded P3 Health Partners from Buy to Neutral

      4/1/24 7:39:12 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • BTIG Research initiated coverage on P3 Health Partners with a new price target

      BTIG Research initiated coverage of P3 Health Partners with a rating of Buy and set a new price target of $5.00

      9/1/23 7:31:24 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • TD Cowen initiated coverage on P3 Health Partners

      TD Cowen initiated coverage of P3 Health Partners with a rating of Market Perform

      6/30/23 7:34:42 AM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Large owner Chicago Pacific Founders Ugp Iii, Llc

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      1/31/25 7:05:33 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • SEC Form 3 filed by new insider Pedersen Leif Elliott

      3 - P3 Health Partners Inc. (0001832511) (Issuer)

      10/1/24 5:35:14 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/13/24 9:56:09 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/13/24 9:56:09 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $128,624 worth of shares (240,000 units at $0.54) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/12/24 8:12:24 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $117,544 worth of shares (240,000 units at $0.49) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/11/24 6:17:20 AM ET
      $PIII
      Medical/Nursing Services
      Health Care